| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Genetics, Vol. 173, 1893-1908, August 2006, Copyright © 2006
doi:10.1534/genetics.105.053025
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






* Department of Biology, Indiana UniversityPurdue University, Indianapolis, Indiana 46202,
Department of Drug Disposition, Eli Lilly, Lilly Corporate Center, Indianapolis, Indiana 46285,
Institute of Human Nutrition, Columbia University Medical Center, New York, New York 10032 and
Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, Kentucky, 40536
3 Corresponding author: Department of Biology, Indiana UniversityPurdue University, 723 W. Michigan St., Indianapolis, IN 46202.
E-mail: mbard{at}iupui.edu
ecm22
in the S288c genetic background is attributable to a mutation in the HAP1 transcription factor. In addition we demonstrate that strains containing upc2
ecm22
are also inviable when carrying deletions of ERG6 and ERG28 but not when carrying deletions of ERG3, ERG4, or ERG5. It has previously been demonstrated that UPC2 and ECM22 regulate S. cerevisiae ERG2 and ERG3 and that the erg2
upc2
ecm22
triple mutant is also synthetically lethal. We used transposon mutagenesis to isolate viable suppressors of hap1
, erg2
, erg6
, and erg28
in the upc2
ecm22
genetic background. Mutations in two genes (YND1 and GDA1) encoding apyrases were found to suppress the synthetic lethality of three of these triple mutants but not erg2
upc2
ecm22
. We show that deletion of YND1, like deletion of GDA1, alters the sphingolipid profiles, suggesting that changes in sphingolipids compensate for lethality produced by changes in sterol composition and abundance.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |